Investigators @hopkinskimmel may soon be able to differentiate Group 4 medulloblastomas (brain tumors) in children from more aggressive Group 3 using a long noncoding RNA that could lead to better-targeted treatments. hopkinsmedicine.org/news/new… via @HopkinsMedNews
We have post-doc positions open for a newly funded NIH R01 grant to study lncRNA therapeutics in cancer at the Johns Hopkins University at Perera lab. Please apply [email protected]
Join me in May for the @KeystoneSymp virtual #eSymposia, #NonCodingRNA: Biology and Applications, to explore emerging research on #lncRNA and network with global experts on interactive platforms. Register now keysym.us/VKSNonCodingRNA21 #VKSNonCodingRNA21
"Long non-coding RNAs in brain tumors"
Keisuke Katsushima, George Jallo, Charles G Eberhart,
Ranjan J Perera lnkd.in/dp5dHnF
Biomarker of Aggressive Childhood Cancer Discovered
hopkinsmedicine.org/news/new…
academic.oup.com/neuro-oncol…
Novel lncRNA RNA HLX2-7 in medulloblastoma by Katsushima et al., in Perera lab.
Post-doc position to study long noncoding RNAs in medulloblastoma-
Perera and Jallo laboratory at the Johns Hopkins University SOM and Center for RNA Biology at the JHACH is looking for a post-doc to study lncRNAs in MB. Please pass the message
[email protected]
A postdoctoral fellow position is open in the Perera laboratory at the Department of Oncology, Johns Hopkins University School of Medicine, and Center for RNA Biology.
email - [email protected]
Thanks-
Bionano Saphyr will definitely revolutionize the cytogenetics in near future. bionanogenomics.com/products…